
Bayer launches Leukine without EDTA
Bayer has reformulated Leukine without EDTA, which has been linked with fainting.
Bayer HealthCare Pharmaceuticals has come out with a liquid Leukine (sargramostim) 500 mcg vial without EDTA (edentate disodium).
Bayer had withdrawn its EDTA version in January since it was associated with fainting. Now that a non-EDTA form is available, Bayer is discontinuing its special program that gave patients with the greatest medical need priority access to lyophilized Leukine 250 mcg vials, which do not contain EDTA.
To see more Daily News articles,
To go to the Drug Topics homepage,
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.





































































































































